“The COVID-19 vaccine manufacturers with the US FDA excluded pregnant women and women of childbearing potential from being studied in randomized trials because of maternal-fetal risks with lipid nanoparticles, mRNA, and PEG. It is strict regulatory practice, that when a group is excluded from the registrational randomized trials of a new product, that group is also prohibited from taking or using that medicine in practice for obvious safety reasons. That consideration is always applied to pregnancy without exception.”